作者
Peter F Wright, Ruth I Connor, Wendy F Wieland-Alter, Anne G Hoen, Austin W Boesch, Margaret E Ackerman, M Steven Oberste, Chris Gast, Elizabeth B Brickley, Edwin J Asturias, Ricardo Rüttimann, Ananda S Bandyopadhyay
发表日期
2016/12/1
期刊
The Lancet infectious diseases
卷号
16
期号
12
页码范围
1377-1384
出版商
Elsevier
简介
Background
Identification of mechanisms that limit poliovirus replication is crucial for informing decisions aimed at global polio eradication. Studies of mucosal immunity induced by oral poliovirus (OPV) or inactivated poliovirus (IPV) vaccines and mixed schedules thereof will determine the effectiveness of different vaccine strategies to block virus shedding. We used samples from a clinical trial of different vaccination schedules to measure intestinal immunity as judged by neutralisation of virus and virus-specific IgA in stools.
Methods
In the FIDEC trial, Latin American infants were randomly assigned to nine groups to assess the efficacy of two schedules of bivalent OPV (bOPV) and IPV and challenge with monovalent type 2 OPV, and stools samples were collected. We selected three groups of particular interest—the bOPV control group (serotypes 1 and 3 at 6, 10, and 14 weeks), the trivalent attenuated OPV (tOPV …
引用总数
201620172018201920202021202220232024147548965